RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Camp Hill, PA · Exton, PA · Pittsburgh, PA · +119 more sites
3 recruiting psoriasis studies with a site in Pittsburgh, PA.
Sponsor: Bristol-Myers Squibb
Camp Hill, PA · Exton, PA · Pittsburgh, PA · +119 more sites
Sponsor: National Cancer Institute (NCI)
Philadelphia, PA · Pittsburgh, PA · +49 more sites
Sponsor: Duke University
Hershey, PA · Philadelphia, PA · +72 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.